GLP-1 coverage in Colorado

Coverage is not only cheaper, it means the prescription sits inside your medical care rather than alongside it. Here is where Colorado stands.

Colorado has the lowest adult obesity prevalence in the United States.

CDC’s 2024 data put Colorado at 25.0%, the lowest of any state — though that still means one adult in four. Every US state and territory recorded a prevalence of at least 25% in 2024. Everything below is sourced — we are not going to tell you what a Colorado clinic charges, because every provider we track is 50-state telehealth and prices the same wherever you live. What actually differs by state is coverage, and that is what this page is about.

Why coverage changes the care, not just the cost

A covered prescription usually sits inside your existing medical relationship, with your own clinician managing dose changes and side effects. A cash-pay telehealth programme sits alongside it. At the doses and ages our readers are dealing with, that difference matters beyond the money.

Medicaid and GLP-1s in Colorado

Coverage for obesity is optional for states — the national picture is on our coverage index. Here is where Colorado sits.

If you are on Medicaid in Colorado

What to do in Colorado: Lower prevalence does not mean lower individual need. The coverage and pricing questions are the same ones as everywhere else.

Coverage for type 2 diabetes, cardiovascular disease and sleep apnea is mandatory everywhere, so a refusal framed around weight loss is not the end of it — and on Medicare, the $50 programme starts 1 July 2026 regardless of which state you are in.

Colorado: common questions

If Colorado has the lowest rate, is obesity a smaller issue here?

Lower than elsewhere, but 25.0% still means one adult in four. Every US state and territory recorded at least 25% in 2024, so Colorado represents the national floor rather than an exception.

Does Colorado Medicaid cover GLP-1s for obesity?

Colorado is not among the states KFF flags as having eliminated coverage or as covering weight-loss drugs without GLP-1s. Check the current formulary directly — positions have moved more than once in the past year.

Sources: KFF, “Medicaid Coverage of and Spending on GLP-1s”, 16 January 2026; CDC Adult Obesity Prevalence Maps, 2024 data, published 3 December 2025. Verified 2026-09-18. Coverage positions change mid-year — confirm yours with your plan. Not medical, legal or benefits advice.